Overview
Claudia Lerma practices in Ignacio Chavez, Mexico. Ms. Lerma is rated as an Advanced expert by MediFind in the treatment of Familial Neurocardiogenic Syncope. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Ectopic Heartbeat, and Familial Neurocardiogenic Syncope.
Her clinical research consists of co-authoring 78 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Familial Neurocardiogenic Syncope.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Kidney DiseaseMs. Lerma isAdvanced. Learn about Chronic Kidney Disease.
- Ectopic HeartbeatMs. Lerma isAdvanced. Learn about Ectopic Heartbeat.
- End-Stage Renal Disease (ESRD)Ms. Lerma isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Familial Neurocardiogenic Syncope
- FibromyalgiaMs. Lerma isAdvanced. Learn about Fibromyalgia.
- Experienced
- Aortic Valve StenosisMs. Lerma isExperienced. Learn about Aortic Valve Stenosis.
- ArrhythmiasMs. Lerma isExperienced. Learn about Arrhythmias.
- Cardiac ArrestMs. Lerma isExperienced. Learn about Cardiac Arrest.
- COVID-19Ms. Lerma isExperienced. Learn about COVID-19.
- Deep Vein ThrombosisMs. Lerma isExperienced. Learn about Deep Vein Thrombosis.
- FaintingMs. Lerma isExperienced. Learn about Fainting.